Search results
Jun 25, 2024 · Variable cytologic appearance and categorization according to the Bethesda system are expected depending on the underlying well differentiated thyroid carcinoma (papillary thyroid carcinoma, follicular thyroid carcinoma, oncocytic thyroid carcinoma)
Jun 10, 2024 · Background. Papillary thyroid carcinoma (PTC) is globally prevalent and associated with an increased risk of lymph node metastasis (LNM). The role of cancer-associated fibroblasts (CAFs) in PTC remains unclear.
Jun 14, 2024 · Three main high-grade subsets of DHGTC based on corresponding histology included papillary thyroid carcinoma (65%), follicular carcinoma (22.5%), and oncocytic carcinoma (12.5%). Over 97% of FNA cases were classified as Bethesda category IV or above.
Jun 10, 2024 · Although most differentiated thyroid carcinoma has a clinically favorable prognosis, some of specific types of thyroid cancer (such as anaplastic thyroid carcinoma and advanced papillary thyroid carcinoma) show fatal outcomes and require novel treatments.
Jun 19, 2024 · Using a panel of 57 genes linked to thyroid cancer, we sequenced the samples to determine the mutation frequency of thyroid cancer-associated genes in PTC. We further analyzed the correlation between gene variants and clinical information.
Jun 21, 2024 · Papillary thyroid carcinoma (PTC) is the most common pathological type of thyroid malignancy, accounting for 90% of all thyroid malignancies. 1 Patients with PTC with non-metastatic thyroid cancer can be successfully treated through surgery, radioactive iodine-131 therapy, and thyroid-stimulating hormone suppression therapy.
Jun 21, 2024 · Abstract. The hobnail variation of papillary thyroid cancer (PTC) is an uncommon, aggressive variety with hobnail characteristics on more than 30% of the tumour cells. Because of the entity’s rarity, the clinical behaviour and pathologic characteristics of these tumours are still unknown.
